Navigation Links
5X Improvement in Z-Motion Range is Big Step Forward for World of Microscopy – N-725 Z-Axis Piezo Positioner by PI
Date:7/19/2013

Auburn, MA (PRWEB) July 19, 2013

Piezo positioners provide sub-nanometer resolution and fast response. Until now, travel ranges have been limited to a few 100 microns, enough for most microscopy applications. A new drive principle developed by PI (Physik Instrumente) now extends the travel range to 2 mm while maintaining very short settling times on the order of 20 milliseconds.

High resolution microscopy methods, such as two-photon microscopy, make it possible to record 3D stacks with up to 1 mm depth in biological samples. Here conventional piezo techniques have posed a limitation. PI’s N-725 piezo-motor objective positioner and scanner breaks with conventional wisdom and helps exploit the new possibilities.

Based on a patented piezo-walk motor, the N-725 provides travel ranges of up to 2 mm along the optical axis to quickly and precisely change the focal plane. Despite its small size, the new device replaces and combines the performance of two individual stages: a fine focus piezo drive and a stepper motor positioner for coarse, long travel motion.

The challenge was to implement the high-stiffness piezo motor in a compact mechanical housing no larger than PI’s previous piezo-direct-actuator based PIFOC® objective stages providing travel ranges from 0.1 to 0.4 mm.

The new long-travel piezo motor provides 5 to 20 times the travel range, sub-nanometer resolution and locks into a position, without further need for power, significantly improving long term stability.

Complete with Controller and Software:

The piezo-z-focus drive comes complete with a powerful motion controller and software. It is compatible with leading microscope imaging suite software packages.

More information is available here: http://www.physikinstrumente.com/en/products/prdetail.php?sortnr=1100210&onl_prw

About PI

The PI group provides the broadest and deepest portfolio of precision motion technologies, from micropositioning to sub-nanometer precision positioning equipment for markets as diverse as semiconductor manufacturing, bio-technology, photonics, aerospace and medical engineering. PI has 4 decades of experience with the design and manufacture of precision positioning systems based on piezoceramic and electromagnetic drives. The company has been ISO 9001 certified since 1994 and provides innovative, high-quality solutions for OEM and research. PI is present worldwide with 10 subsidiaries, R&D / engineering on 3 continents and total staff of 750+.

Read the full story at http://www.prweb.com/releases/2013/7/prweb10947525.htm.


'/>"/>
Source: PRWeb
Copyright©2012 Vocus, Inc.
All rights reserved

Related biology technology :

1. The MedZilla.com Employment Report for July, 2013: Nation's Economy Makes Substantial, Demonstrable Improvements
2. New Analysis Yields Improvements in Classic 3D Imaging Technique
3. ComplianceOnline Announces Seminar on Clinical Trial Project Supplier Quality Improvement
4. Neuralstem Cells Induce Significant Functional Improvement In Permanent Rat Spinal Cord Injury, Cell Study Reports
5. Dr. Ross Kaplan Offers New State-of-the-Art Wrinkle, Fine Line, and Skin Texture Improvement Treatment
6. Foundation for Health Improvement and Technology (FHIT) Launched to Beat Cardiovascular Disease
7. REVIVE Trial Results for Avanafil Published in JSM Demonstrate Significant Improvement in Erectile Function
8. Nanounity Introduces the Pemtron Range of Compact Scanning Electron Microscopes
9. iLuv Introduces a Range of Accessories to Enhance Apple’s Lightning Devices at 2013 CES
10. New Revolutionary Femoral Access Site Closure Device Shows Unparalleled Efficacy, Safety & Ease of Use, in a Wide Range of Patients Including Patients With a Challenging Anatomy
11. Strange cousins: Molecular alternatives to DNA, RNA offer new insight into lifes origins
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/28/2017)... ... , ... Over 8,000 recognized rare diseases afflict an estimated 350 million people ... March 7, DrugDev will gather international experts to share challenges and provide insight and ... Overcoming the Challenges of Rare Disease Clinical Trials, Date: March 7, 2017, Time: 10:00-11:00 ...
(Date:2/28/2017)... , ... February 28, 2017 , ... ... discovery of antibody therapeutics from millions-diverse immune repertoires, today announced a strategic partnership ... mouse strains genetically engineered to express human antibodies. The partnership will use GigaGen ...
(Date:2/28/2017)... PHILADELPHIA , Feb. 28, 2017 ... company focusing on debilitating diseases including rare genetic diseases ... the company joins with the National Organization for Rare ... support around the world in commemorating Rare Disease Day, ... and needs of the millions of patients and families ...
(Date:2/28/2017)... VANCOUVER , Feb. 28, 2017 /PRNewswire/ - RepliCel ... "Company"), a clinical stage regenerative medicine company developing unique ... and sun-damaged skin, and chronic tendon degeneration, today announced ... both of whom have committed to work with RepliCel ... manufactured and tested. ...
Breaking Biology Technology:
(Date:2/1/2017)... , February 1, 2017 IDTechEx Research, a ... emerging technology, announces the availability of a new report, Sensors ... Continue Reading ... ... and collaborative robots. Source: IDTechEx Report "Sensors for Robotics: Technologies, Markets ...
(Date:1/30/2017)... --  Invitae Corporation (NYSE: NVTA ), ... announced that it will report its fourth quarter and ... Monday, February 13, 2017, and Invitae,s management team will ... Eastern / 1:45 p.m. Pacific. During ... results, guidance, and recent developments and will spend the ...
(Date:1/26/2017)... Jan. 26, 2017  Acuity Market Intelligence today ... and Digital Identity".  Acuity characterizes 2017 as a ... increased adoption reflects a new understanding of the ... "Biometrics and digital identity are often perceived as ... Most , Principal of Acuity Market intelligence. "However, ...
Breaking Biology News(10 mins):